1. Home
  2. KXIN vs ACON Comparison

KXIN vs ACON Comparison

Compare KXIN & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KXIN

Kaixin Auto Holdings

HOLD

Current Price

$5.17

Market Cap

7.0M

ML Signal

HOLD

Logo Aclarion Inc.

ACON

Aclarion Inc.

HOLD

Current Price

$2.73

Market Cap

7.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
KXIN
ACON
Founded
2015
2008
Country
China
United States
Employees
N/A
N/A
Industry
Retail-Auto Dealers and Gas Stations
Retail: Computer Software & Peripheral Equipment
Sector
Consumer Discretionary
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
7.0M
7.4M
IPO Year
2017
2022

Fundamental Metrics

Financial Performance
Metric
KXIN
ACON
Price
$5.17
$2.73
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
100.3K
45.6K
Earning Date
11-26-2019
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
99.82
EPS
N/A
N/A
Revenue
N/A
$75,730.00
Revenue This Year
N/A
$87.22
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
65.62
52 Week Low
$0.11
$1.95
52 Week High
$22.00
$12.03

Technical Indicators

Market Signals
Indicator
KXIN
ACON
Relative Strength Index (RSI) 48.10 52.82
Support Level $4.05 $2.38
Resistance Level $5.86 $3.54
Average True Range (ATR) 0.31 0.16
MACD -0.04 0.05
Stochastic Oscillator 58.98 87.69

Price Performance

Historical Comparison
KXIN
ACON

About KXIN Kaixin Auto Holdings

Kaixin Holdings is an auto dealership company mainly engaged in the sale of domestic and imported automobiles in China. The company provides new and used car buyers in China with access to a wide selection of used vehicles across its network of dealerships, with a focus on premium brands such as Audi, BMW, Mercedes-Benz, Land Rover, and Porsche. The company generates revenue from automobile sales and related services.

About ACON Aclarion Inc.

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.

Share on Social Networks: